Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed-Refractory to IMiDs and Proteasome Inhibitors, Turkish Journal of Hematology, March 2017, Journal of Clinical Research of Pediatric Endocrinology,
DOI: 10.4274/tjh.2016.0397.
You can read the full text:
Contributors
The following have contributed to this page